.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Chinese Patent Office
Queensland Health
US Department of Justice
Novartis
Medtronic
US Army
QuintilesIMS
Boehringer Ingelheim

Generated: December 15, 2017

DrugPatentWatch Database Preview

ODOMZO Drug Profile

« Back to Dashboard

Which patents cover Odomzo, and what generic alternatives are available?

Odomzo is a drug marketed by Sun Pharma Global and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred patent family members in forty-six countries and ten supplementary protection certificates in eight countries.

The generic ingredient in ODOMZO is sonidegib phosphate. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sonidegib phosphate profile page.

Summary for ODOMZO

Drug patent expirations by year for ODOMZO

Pharmacology for ODOMZO

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sun Pharma GlobalODOMZOsonidegib phosphateCAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Sun Pharma GlobalODOMZOsonidegib phosphateCAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Sun Pharma GlobalODOMZOsonidegib phosphateCAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ODOMZO

Country Document Number Estimated Expiration
Spain2552347► Subscribe
European Patent Office2363393► Subscribe
South Africa200808962► Subscribe
Japan2012502912► Subscribe
EcuadorSP088860► Subscribe
Israel211412► Subscribe
Jordan2883► Subscribe
EcuadorSP11010985► Subscribe
Japan2012097104► Subscribe
Argentina060858► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ODOMZO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016000001Germany► SubscribePRODUCT NAME: SONIDEGIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT ODER SOLVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1030 20150814
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
2015051,C2021328Lithuania► SubscribePRODUCT NAME: SONIDEGIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, HIDRATAS ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
883Luxembourg► SubscribePRODUCT NAME: SONIDEGIB OU UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE; FIRST REGISTRATION: 20150818
C0077France► SubscribePRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
90062-4Sweden► SubscribePRODUCT NAME: SONIDEGIB OR A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF; REG. NO/DATE: EU/1/15/1030 20150818
5 5026-2015Slovakia► SubscribePRODUCT NAME: SONIDEGIB VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2015051Lithuania► SubscribePRODUCT NAME: SONIDEGIBUM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
0790Netherlands► SubscribePRODUCT NAME: SONIDEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/15/1030 (C(2015)5890) 20150818
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Chinese Patent Office
Medtronic
Cantor Fitzgerald
McKesson
Cerilliant
Deloitte
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot